Wang, Xiwu
Ye, Teng
Zhou, Wenjun
Zhang, Jie
,
Article History
Received: 6 December 2022
Accepted: 12 March 2023
First Online: 20 March 2023
Declarations
:
: Each ADNI participant or authorized representative provided written informed consent, and the institutional review board of each participating ADNI site approved the ADNI study. This study was conducted in accordance with the Declaration of Helsinki. This project was also submitted for review to the institutional review board of Wenzhou Seventh People’s Hospital. However, given that this study did not involve contact with human subjects and used de-identified data, the institutional review board of Wenzhou Seventh People’s Hospital determined this study did not require review.
: Not applicable.
: Jie Zhang serves as the Founder of Hangzhou Shansier Medical Technologies Co., Ltd., and holds shares in Hangzhou Shansier Medical Technologies Co., Ltd., which is dedicated to digitizing clinical practice and research. Wenjun Zhou is employed by Hangzhou Shansier Medical Technologies Co., Ltd., and holds shares in Hangzhou Shansier Medical Technologies Co., Ltd. The other authors declare that they have no competing interests.